Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Drops By 75.8%

BIO-key International Inc. (NASDAQ:BKYI) was the recipient of a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 310,850 shares, a drop of 75.8% from the January 29th total of 1,284,522 shares. Approximately 3.0% of the shares of the company are short sold. Based on an average daily volume of 357,109 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily volume of 357,109 shares, the days-to-cover ratio is currently 0.9 days. Approximately 3.0% of the shares of the company are short sold.

BIO-key International Trading Up 12.4%

Shares of BIO-key International stock opened at $0.62 on Thursday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13. The firm has a fifty day moving average price of $0.61 and a 200 day moving average price of $0.72. BIO-key International has a 1 year low of $0.51 and a 1 year high of $1.97. The stock has a market cap of $6.72 million, a PE ratio of -0.60 and a beta of 0.41.

Institutional Trading of BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC increased its stake in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 as of its most recent filing with the Securities & Exchange Commission. 26.51% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on BKYI shares. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. Wall Street Zen upgraded BIO-key International to a “sell” rating in a research note on Saturday, January 3rd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.